Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Boston Scientific sells TriVascular endovascular aortic repair business

Boston Scientific : 31 March, 2008  (Company News)
Boston Scientific has sold Boston Scientific Santa Rosa , formerly known as TriVascular, to TV2 Holding, a privately held company based in Santa Rosa, California. Boston Scientific Santa Rosa holds equipment and intellectual property related to the TriVascular endovascular aortic repair (EVAR) programme.
Terms of the sale include $30 million in cash paid at closing to Boston Scientific and a warrant allowing Boston Scientific to purchase a minority interest in TV2.

Boston Scientific acquired TriVascular, which was founded to develop EVAR devices and procedures for treating abdominal aortic aneurysms, in April 2005. Boston Scientific discontinued its EVAR programme in 2006.

'The sale of this business is the latest example of Boston Scientific's commitment to divesting non-strategic assets,' said Jim Tobin, president and chief executive officer of Boston Scientific. 'These divestitures - together with our expense and head count reductions and business restructuring - are helping realign our cost structure and simplify our operating model as we progress toward achieving our overall goals of restoring profitable growth, increasing shareholder value and strengthening Boston Scientific for the future.'
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo